ABOUT US

Purpose and Strategy

Secure the core of the healthcare value chain

At EUROAPI, our strategy is guided by our purpose: to secure the core of the healthcare value chain.

This is our contribution to the world, the deep conviction that motivates our teams every day.

It is a critical part of who we are.

  • Secure: we safeguard access to essential medicines that society depends on. We take pride in our commitment to this vital societal cause, as highlighted by the COVID crisis. With a resilient supply chain, we ensure the continuity of supply and provide pharmaceutical and biotech companies with the reliability they need.
  • The core: we specialize in active pharmaceutical ingredients (APIs), the molecules that give medicines their therapeutic effect. APIs are the fundamental hidden ingredients that play an essential role in treatments.
  • The healthcare value chain: our APIs are part of the healthcare value chain that starts with early-stage R&D and ends with pharmaceutical formulation.

OUR VISION

At EUROAPI, we have a vision to build together the future of public health by advancing and securing access to essential active ingredients.

  • Our shared and purpose-driven objective is to guarantee access to the essential active ingredients to improve and protect the health of populations.
  • This goal is closely tied to healthcare sovereignty to reduce dependence on fragile global supply chains and strengthen healthcare resilience.

OUR MISSION

At EUROAPI, our mission is to provide our clients with high-quality and sustainable API solutions, driven by a collective commitment to public health and new drug development.

  • We position ourselves as a high-quality service provider with a dual model as a proprietary API producer and Contract Development and Manufacturing Organization.
  • Our B2B approach reflects our commitment to providing innovative, customized, and sustainable API solutions. 

Who we are

EUROAPI is focused on reinventing active pharmaceutical ingredients to sustainably meet customers’ and patients’ needs around the world.

We are a leading player with approximately 200 products in our portfolio, offering a large span of technologies while also developing innovative molecules through our Contract Development and Manufacturing Organization (CDMO) activities.

Our Strategic Ambition

EUROAPI’s ambition is to be the European-based sovereign supplier of complex APIs, a reliable CMO partner, and a trusted CDMO for new drug development.

Our ambition is based on 3 strategic pillars:

  • Growth through differentiated value proposition

    Driving growth through compelling value propositions (API, CMO, CDMO), commercial excellence, and targeted geographic expansion.

  • Scalable, competitive and efficient operations

    Ensuring consistent quality and reliable supply across our operations at optimized cost and with greater agility and resilience.

  • Organizational transformation for sustainable success

    Building a lean and agile organization enabled by empowered teams committed to sustainable performance.

Our values

Our people are united by four core values. These foundational principles are shared across the organization. At EUROAPI, we strongly believe without compromise in:

  • OWNERSHIP

    Embracing ownership means that we are driven by the impact of our actions, our work on public health and the growth of our company.

  • PASSION

    We are committed to excellence in execution, serving our clients and partners while strengthening our teams and driving company performance through innovation.

  • COLLABORATION

    Collaboration & trust are the foundations of how we work. We believe progress is achieved together, across our teams and with our clients, celebrating shared success.

  • CARE

    At EUROAPI, care means acting with sustainability, respect, and integrity toward all our stakeholders, while striving for constant improvement in everything we do.